Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Overview of attention for article published in Molecular Neurodegeneration, July 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 873)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 5 news outlets

twitter: 8 tweeters

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 112 Mendeley

Summary News Twitter Dimensions citations

So far, Altmetric has seen 5 news stories from 5 outlets.

Scientists and biohackers are popping this $1 cancer drug to stop their cells from aging

Business Insider India, 10 Mar 2023

Rapamycin is a medicine typically used for kidney transplants and some cancers.

Scientists and biohackers are popping this $1 cancer drug to stop their cells from aging

Yahoo! News, 10 Mar 2023

Rapamycin is a medicine typically used for kidney transplants and some cancers.

Scientists and biohackers are popping this $1 cancer drug to stop their cells from aging

Business Insider Nederland, 10 Mar 2023

Rapamycin is a medicine typically used for kidney transplants and some cancers.

Scientists and biohackers are popping this $1 cancer drug to stop their cells from aging

Newsbreak, 10 Mar 2023

Rapamycin is a medicine typically used for kidney transplants and some cancers.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.